Qiming Venture Partners Welcomes Apollomics’ Successful IPO on Nasdaq
- On March 30, 2023, Apollomics Inc. ("Apollomics"), an innovative biopharmaceutical company and portfolio company of Qiming Venture Partners, listed on Nasdaq through a SPAC merger...
